Search

Your search keyword '"Michael G. Schrauder"' showing total 79 results

Search Constraints

Start Over You searched for: Author "Michael G. Schrauder" Remove constraint Author: "Michael G. Schrauder"
79 results on '"Michael G. Schrauder"'

Search Results

1. Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease—the 'Breast cancer care for patients with metastatic disease' (BRE-4-MED) registry

2. Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy

Catalog

Books, media, physical & digital resources

3. Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia)

4. Abstract P4-17-06: Treatment strategies in male breast cancer: Results of a prospective multicenter study

5. Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany: Initial Data from the AXSANA study

6. Effects of pomegranate seed oil and fermented juice polyphenols fraction in different solvents on copper-induced LDL oxidation

7. Should Breast Cancer Surgery Be Done in an Outpatient Setting?

8. Chylous ascites after lymphadenectomy for gynecological malignancies

9. Versorgungsnetze in der Onkologie

10. MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer

11. (Neo-)Adjuvanten und First-Line-Therapie

12. BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients

13. Budget impact analysis of gene expression tests to aid therapy decisions for breast cancer patients in Germany

14. Plastische Rekonstruktionen der Mamma mittels Fremdgewebe

15. Circulating miR-148b and miR-133a as biomarkers for breast cancer detection

16. Shared decision-making in metastatic breast cancer: discrepancy between the expected prolongation of life and treatment efficacy between patients and physicians, and influencing factors

17. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis

18. Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer

20. Chylous ascites after lymphadenectomy for gynecological malignancies

21. Financing of certified centers: a willingness-to-pay analysis

22. Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians

25. Gesundheitsökonomische Aspekte und finanzielle Probleme in den zertifizierten Strukturen des Fachgebietes

26. The Hohl instrument for optimizing total laparoscopic hysterectomy: results of more than 500 procedures in a university training center

27. Diabetes and prognosis in a breast cancer cohort

28. Assessment of mammographic density before and after first full-term pregnancy

30. Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patients

31. Ultraschall im 1. Trimenon

32. Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer

33. Increased Accuracy of Fetal Weight Estimation with a Gender-Specific Weight Formula

34. The PI3K Pathway: Background and Treatment Approaches

35. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

36. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients

37. Hormonapplikation und gynäkologische Tumortherapie

38. Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk

39. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor

40. Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases

42. Impact of single nucleotide polymorphisms RS1870377 A>T and RS2305948 C>T on endothelial cell activation under non-uniform shear stress

43. Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients

45. Relevance of health economics in breast cancer treatment - the view of certified breast centres and their patients

46. Health utilities in gynecological oncology and mastology in Germany

47. Polymorphisms in the RANK/RANKL genes and their effect on bone specific prognosis in breast cancer patients

48. miRNAs can be generally associated with human pathologies as exemplified for miR-144

49. Comprehensive visualization of paresthesia in breast cancer survivors

50. Fetal Adrenal Haemorrhage – Two-Dimensional and Three-Dimensional Imaging